Synthesis and antituberculosis activity of new 3-alkylsulfanyl-1,2,4-triazole derivatives

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 20, Issue 2, 2005, Pages 179-182

  Kaplancikli, Zafer Asim ^a   Turan Zitouni, Gülhan ^a   Chevallet, Pierre ^b  

^a ANADOLU UNIVERSITY   (Turkey)

^b UNIV MONTPELLIER   (France)

Author keywords

1,2,4 triazole; Antituberculosis activity

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 4 AMINO 3 MERCAPTO 5 (2 THIENYLMETHYL) 1,2,4 TRIAZOLE; 4 AMINO 5 (2 THIENYLMETHYL) 3 [1 (2 THIENYL) 3 ARYLPROPION 3 YL]SULFANYL 4H 1,2,4 TRIAZOLE DERIVATIVE; ANTIMYCOBACTERIAL AGENT; CHALCONE DERIVATIVE; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CHEMICAL REACTION; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; DRUG SYNTHESIS; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RADIOMETRY;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; CHALCONES; CULTURE MEDIA; MICROBIAL SENSITIVITY TESTS; MODELS, CHEMICAL; MYCOBACTERIUM TUBERCULOSIS; OXAZINES; TEMPERATURE; THIAZOLES; TRIAZOLES; XANTHENES;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 18444394637     PISSN: 14756366     EISSN: None     Source Type: Journal    
DOI: 10.1080/14756360500043471     Document Type: Article

References (25)

1. WHO Web site, http://www.who.org and NIAID Web site, http://www.niaid.nih.gov/factsheets/tb.htm
2. Snider DE, Castro KG. N Engl J Med 1998;338:1689-1690.
3. Sbardella G, Mai A, Artico M, Loddo R, Setzu MG, La Colla P. Bioorg Med Chem Lett 2004;14:1537-1541.
4. Crabb Ch. Bull World Health Organ 2002;80:517-517.
5. Waisser K, Hladuvkova J, Hrabalek A, Klimesova V, Kubicova L, Kunes J, Palat K, Machacek M, Vinsova J, Buchta V, Jilek P, Odlerova Z. Folia Pharm Univ Carol 1998;21-22:69-81.
6. Klimesová V, Koci J, Zahajska L. Ces Slov Farm 2002;51:26-36.
7. Klimesová V, Zahajska L, Waisser K, Kaustová J, Möllman U. Farmaco 2004;59:279-288.
8. Kunes J, Spulak M, Waisser K, Slosarak M, Janota J. Pharmazie 2000;55:858-859.
9. Scozzafava A, Mastrolorenzo A, Supuran CT. Bioorg Med Chem Lett 2002;11:1675-1678.
10. Klimesová V, Kocí J, Pour M, Stachel J, Waisser K, Kaustová J. Eur J Med Chem 2002;37:409-418.
11. Klimesová V, Koci J, Waisser K, Kaustová J. Farmaco 2002;57:259-265.
12. Koci J, Klimesová V, Waisser K, Kaustová J, Dahse HM, Möllman U. Bioorg Med Chem Lett 2002;12:3275-3278.
13. Klimesová V, Svoboda M, Waisser K, Pour M, Kaustová J. Farmaco 1999;54:666-672.
14. Klimesová V, Svoboda M, Waisser K, Kaustová J, Buchta V, Kralova K. Eur J Med Chem 1999;34:433-440.
15. Klimesová V, Svoboda M, Waisser K, Machacek M, Buchta V, Odlerova Z. Arch Pharm (Pharm Med Chem) 1996;329:438-442.
16. Mir I, Siddiqui MT. Tetrahedron 1970;26:5235-5238.
17. Gülerman NN, Doǧan HN, Rollas S, Johansson C, Çelik C. Farmaco 2001;56:953-958.
18. Duca CJ, Rothlauf MV, Scudi JV. Antibiot Chemother 1952;2:16-20.
19. Nobles WL, Burckhalter JH. J Am Pharm Assoc 1953; 42:176-178.
20. Caldwell HC, Nobles WL. J Am Pharm Assoc 1956; 45:729-732.
21. Fujikawa F. Japan 14,685 (1962). Chem Abst 1965: 62: 527.
22. Masao K. Hiroshi T. Jpn. Pat., 21,420 (1986). Chem Abst 1986;105:642097.
23. Turan-Zitouni G, Kaplancikli ZA, Kiliç FS, Erol K. Boll Chim Farm 2002;141:192-196.
24. Dawey W, Tivey DJ. J Chem Soc 1958;80:1230-1236.
25. Collins L, Franzblau SG. Antimicrob Agents Chemother 1997;41:1004-1009.